K C Hazen1. 1. Department of Pathology, University of Virginia Medical Center, Charlottesville 22908, USA.
Abstract
BACKGROUND: The ratio of fungicidal to fungistatic activity of two new antifungal agents, itraconazole and terbinafine, against the causative organisms in onychomycosis may have clinical relevance. OBJECTIVE: This study compared the fungistatic and fungicidal activity of terbinafine and itraconazole against clinical isolates of dermatophytes and Candida species causing onychomycosis. METHODS: The antifungal agent was added to suspensions of dermatophyte conidia and hyphal fragments (5 x 10(3) to 5 x 10(4) fungal elements/ml) that had been preincubated to allow hyphal formation. Cell suspensions of Candida species (1 to 5 x 10(3) cells/ml) were not preincubated before drug exposure. Macrobroth and macrobroth dilution assays were used to test antifungal susceptibility of dermatophytes and yeasts, respectively. An agent was considered fungicidal if the minimal fungicidal concentration (MFC) to minimal inhibitory concentration (MIC) ratio was < or = 4 and fungistatic if the ratio was > 4. Cell death was also visualized by a vital stain. RESULTS: For both itraconazole and terbinafine, the MIC for dermatophytes was low. The MFCs and MFC/MIC ratios for terbinafine against dermatophytes were lower than for itraconazole; the fungicidal activity of terbinafine was excellent and initiated rapidly (by 7 hours) and that of itraconazole was poor (fungicidal activity was not evident until 10 to 12 hours). For yeasts, the MICs were higher than for dermatophytes, and the differences between itraconazole and terbinafine were less pronounced. CONCLUSION: Both itraconazole and terbinafine inhibit growth of dermatophytes. The more rapid fungicidal activity of terbinafine may have clinical relevance in the treatment of onychomycosis.
BACKGROUND: The ratio of fungicidal to fungistatic activity of two new antifungal agents, itraconazole and terbinafine, against the causative organisms in onychomycosis may have clinical relevance. OBJECTIVE: This study compared the fungistatic and fungicidal activity of terbinafine and itraconazole against clinical isolates of dermatophytes and Candida species causing onychomycosis. METHODS: The antifungal agent was added to suspensions of dermatophyte conidia and hyphal fragments (5 x 10(3) to 5 x 10(4) fungal elements/ml) that had been preincubated to allow hyphal formation. Cell suspensions of Candida species (1 to 5 x 10(3) cells/ml) were not preincubated before drug exposure. Macrobroth and macrobroth dilution assays were used to test antifungal susceptibility of dermatophytes and yeasts, respectively. An agent was considered fungicidal if the minimal fungicidal concentration (MFC) to minimal inhibitory concentration (MIC) ratio was < or = 4 and fungistatic if the ratio was > 4. Cell death was also visualized by a vital stain. RESULTS: For both itraconazole and terbinafine, the MIC for dermatophytes was low. The MFCs and MFC/MIC ratios for terbinafine against dermatophytes were lower than for itraconazole; the fungicidal activity of terbinafine was excellent and initiated rapidly (by 7 hours) and that of itraconazole was poor (fungicidal activity was not evident until 10 to 12 hours). For yeasts, the MICs were higher than for dermatophytes, and the differences between itraconazole and terbinafine were less pronounced. CONCLUSION: Both itraconazole and terbinafine inhibit growth of dermatophytes. The more rapid fungicidal activity of terbinafine may have clinical relevance in the treatment of onychomycosis.
Authors: B Fernández-Torres; A J Carrillo; E Martín; A Del Palacio; M K Moore; A Valverde; M Serrano; J Guarro Journal: Antimicrob Agents Chemother Date: 2001-09 Impact factor: 5.191
Authors: Rafaelle Fonseca de Matos; Lúcia Carla Vasconcelos Mendonça; Kaira Geiliane da Silva Souza; Adriana Aparecida Durães Fonseca; Elaine Mirla Souza Costa; Marcus Vinicius Dias de Lima; José Maria Dos Santos Vieira; Mioni Thielli Figueiredo Magalhães de Brito; Marta Chagas Monteiro Journal: Folia Microbiol (Praha) Date: 2016-11-19 Impact factor: 2.099
Authors: Glaucia Francesconi; Antonio Carlos Francesconi do Valle; Sonia Lambert Passos; Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; André Luiz Land Curi; José Liporage; Cássio Ferreira Porto; Maria Clara Gutierrez Galhardo Journal: Mycopathologia Date: 2010-11-21 Impact factor: 2.574
Authors: Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij Journal: Antimicrob Agents Chemother Date: 2002-10 Impact factor: 5.191